Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:1805-1809, doi:10.1016/j.jacc.2009.07.030
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Go to related CVN interview Interview
Right arrow Go to related CVN interview
Right arrow View Related Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eleid, M. F.
Right arrow Articles by Tajik, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eleid, M. F.
Right arrow Articles by Tajik, A. J.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: CARDIAC EFFECTS OF SLEEP APNEA

High Prevalence of Abnormal Nocturnal Oximetry in Patients With Hypertrophic Cardiomyopathy

Mackram F. Eleid, MD*, Tomas Konecny, MD{dagger}, Marek Orban, MD{dagger}, Partho P. Sengupta, MD, DM*, Virend K. Somers, MD, PhD{dagger}, James M. Parish, MD*, Farouk Mookadam, MBBS*, Peter A. Brady, MD{dagger}, Barbara L. Sullivan, NP*, Bijoy K. Khandheria, MD*, Steve R. Ommen, MD{dagger} and A. Jamil Tajik, MD*,*

* Divisions of Cardiovascular and Pulmonary Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Scottsdale, Arizona
{dagger} Divisions of Cardiovascular and Pulmonary Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota

Manuscript received March 19, 2009; revised manuscript received July 20, 2009, accepted July 30, 2009.

* Reprint requests and correspondence: Dr. A. Jamil Tajik, Cardiovascular Diseases, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, Arizona 85259 (Email: jtajik{at}mayo.edu).

Objectives: We sought to determine the prevalence of nocturnal oxygen desaturation and obstructive sleep apnea (OSA) in a population of patients with hypertrophic cardiomyopathy (HCM).

Background: The coexistence of sleep apnea and HCM, 2 common cardiovascular conditions, has been largely unrecognized in the treatment of patients with HCM. The nocturnal hypoxia-induced hyperadrenergic state in OSA is expected to worsen hemodynamics and outcomes in HCM.

Methods: One hundred subjects with HCM between June 1, 2006, and July 14, 2008, were screened with nocturnal oximetry. Clinical variables were collected for statistical analysis. Oximetry was classified abnormal (suspicion of sleep-disordered breathing) in the presence of repetitive desaturation (≥5 events/h) followed by a rapid return to baseline oxygen saturation (SaO2) level with a decrease of ≥4% and threshold of 90%.

Results: Seventy-one (71%) patients with HCM had abnormal nocturnal oximetry (71 ± 9%, 95% confidence interval: 62% to 80%). Subjects with abnormal oximetry were older (age 59.5 ± 15.3 years) and more were hypertensive (n = 39 [55%]) than those with normal oximetry (age 45.8 ± 18.5 years, n = 9 [31%], p < 0.001, p = 0.03). Patients with HCM were more symptomatic in the presence of abnormal oximetry (New York Heart Association functional class II to III) (62% vs. 83%, p = 0.023). HCM patients had a higher prevalence of abnormal nocturnal oximetry (n = 71, 71%) compared with a control group of similar age and sex distribution (n = 49, 49%) (p = 0.001).

Conclusions: Abnormal nocturnal oximetry is common in patients with HCM, suggesting that OSA is prevalent. OSA may impact hemodynamics and symptoms in HCM. Further studies are needed to determine the long-term benefit of OSA treatment on hemodynamics and disease progression in HCM.

Key Words: hypertrophic • apnea • oximetry • obstructive

Abbreviations and Acronyms
  BMI = body mass index
  CPAP = continuous positive airway pressure
  HCM = hypertrophic cardiomyopathy
  LV = left ventricle/ventricular
  NYHA = New York Heart Association
  OSA = obstructive sleep apnea
  SaO2 = oxygen saturation


Related Articles

Obstructive Sleep Apnea: A Respiratory Syndrome With Protean Cardiovascular Manifestations
Ian Wilcox and Christopher Semsarian
J. Am. Coll. Cardiol. 2009 54: 1810-1812. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A40. [Full Text] [PDF]



This article has been cited by other articles:


Home page
ChestHome page
R. P. Pedrosa, L. F. Drager, P. R. Genta, A. C. S. Amaro, M. O. Antunes, A. Y. Matsumoto, E. Arteaga, C. Mady, and G. Lorenzi-Filho
Obstructive Sleep Apnea Is Common and Independently Associated With Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Chest, May 1, 2010; 137(5): 1078 - 1084.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol., January 26, 2010; 55(4): 380 - 407.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Wilcox and C. Semsarian
Obstructive Sleep Apnea: A Respiratory Syndrome With Protean Cardiovascular Manifestations
J. Am. Coll. Cardiol., November 3, 2009; 54(19): 1810 - 1812.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement